90389-86-9 Usage
Uses
Used in Research Applications:
3-FPM is utilized as a research chemical for studying the effects of selective dopamine and norepinephrine reuptake inhibition on neurotransmitter levels in the brain. This helps scientists to better understand the mechanisms of action and potential therapeutic applications related to these neurotransmitters.
Used in Pharmaceutical Development:
Although not approved for medical use, 3-FPM may be explored in the development of pharmaceuticals targeting conditions related to dopamine and norepinephrine imbalances. Its mechanism of action could provide insights into the development of new treatments for neurological and psychiatric disorders.
Used in Controlled Substances Regulation:
Due to its potential for abuse and the lack of comprehensive safety data, 3-FPM is used as a case study in the regulation of controlled substances. Its classification and control measures can inform the development of policies and guidelines for the management of similar compounds in the future.
Check Digit Verification of cas no
The CAS Registry Mumber 90389-86-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,3,8 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 90389-86:
(7*9)+(6*0)+(5*3)+(4*8)+(3*9)+(2*8)+(1*6)=159
159 % 10 = 9
So 90389-86-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H14FN/c1-2-6-12-8-9-4-3-5-10(11)7-9/h3-5,7,12H,2,6,8H2,1H3
90389-86-9Relevant academic research and scientific papers
Benzylamines: Synthesis and evaluation of antimycobacterial properties
Meindl,Von Angerer,Schonenberger,Ruckdeschel
, p. 1111 - 1118 (2007/10/02)
The synthesis of benzylamines with various N-alkyl chains and substituents in the aromatic system as well as their evaluation on Mycobacterium tuberculosis H 37 Ra are described. The most active compounds in this test, N-methyl-3-chlorobenzylamine (MIC 10.2 μg/mL), N-methyl-3,5-dichlorobenzylamine (93, MIC 10.2 μg/mL), and N-butyl-3,5-difluorobenzylamine (MIC 6.4 μg/mL), also exhibited a marked inhibitory effect on Mycobacterium marinum and Mycobacterium lufu used for the determination of antileprotic properties. The combination of 93 with aminosalicylic acid, streptomycin, or dapsone exert marked supra-additive effects on M. tuberculosis H 37 Ra.
